Ask Warren

Wooree Bio

082850 · KOSDAQ · ₩082850 · 우리바이오

₩3,895▼ ₩240 (5.80%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩316B₩269B₩251B₩264B₩231B₩298B₩290B₩348B
Cost of sales₩286B₩246B₩229B₩238B₩208B₩274B₩266B₩315B
Gross profit₩31B₩24B₩21B₩26B₩23B₩24B₩24B₩34B
Operating income−₩2.4B−₩4.3B₩154M₩2.4B−₩2.3B₩775M−₩4B₩6.2B
Net income−₩3.2B₩351M−₩13B₩13B−₩9.7B−₩528M₩6.5B−₩6.4B
Net income to shareholders−₩179M₩2.2B−₩977M₩2.5B−₩10B−₩521M−₩5.6B₩3.5B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩873B₩868B₩762B₩782B₩747B₩843B₩610B₩646B
Current assets₩666B₩668B₩569B₩589B₩557B₩642B₩405B₩461B
Cash and equivalents₩128B₩141B₩107B₩89B₩112B₩57B₩69B₩76B
Total liabilities₩610B₩602B₩501B₩523B₩495B₩577B₩341B₩377B
Current liabilities₩578B₩551B₩451B₩472B₩445B₩519B₩281B₩323B
Borrowings₩135B₩123B₩117B₩113B₩103B₩112B₩104B₩101B
Total equity₩263B₩266B₩261B₩259B₩253B₩266B₩269B₩269B
Shareholders' equity₩213B₩211B₩205B₩204B₩196B₩209B₩212B₩213B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩14B₩34B₩15B−₩18B₩59B−₩21B₩9.7B₩469M
Capital spending₩7B₩2.6B₩6.7B₩4.3B₩9B₩1.8B₩8.1B₩63B
Free cash flow−₩21B₩31B₩8.3B−₩22B₩50B−₩23B₩1.5B−₩62B
Dividends paid₩944M₩635M——————

Consolidated where available. Amounts in won.

Also known as: Wooree Bio / 우리바이오 / 082850 / KRX:082850

Source: KRX statistical information